Fig. 1: Ezh2 is translocated to the cytoplasm in cardiac M2-like immunomodulatory macrophages in vivo. | Nature Communications

Fig. 1: Ezh2 is translocated to the cytoplasm in cardiac M2-like immunomodulatory macrophages in vivo.

From: Ezh2 emerges as an epigenetic checkpoint regulator during monocyte differentiation limiting cardiac dysfunction post-MI

Fig. 1

Representative pictures of cardiac immunostaining for Ezh2 in a Cd11b+/Cd68- monocytes, b Cd68+/iNos+, c Cd68+/Cd86+, d Cd68+/MHCII+ pro-inflammatory differentiated macrophages, e Cd68+/Cd206+ immunomodulatory differentiated macrophages at 24 h after coronary ligation in mice to induce MI or f Cd68+/Cd206+, g Cd68+/Lyve1+ cardiac-resident immunomodulatory in healthy sham mice. Nuclei were stained with DAPI (blue), myeloid markers were Cd11b (red, panel a), Cd68 (green, panels ag), iNos (red, panel b), Cd86 (red, panel c), MHCII (red, panel d) Cd206 (red, panels e and f) and Lyve1 (red, panel g). Ezh2 (yellow) cellular localization was observed in each cell type but only appeared in immunomodulatory macrophages cytoplasm. Arrows indicate monocytes (white), non-determined macrophages (yellow), pro-inflammatory (green) and immunomodulatory macrophages (red), scale bars represent 25 μm. These cardiac immunostainings have been reproduced at least on three different mice with similar results.

Back to article page